Iktos, which specialises in artificial intelligence (AI) for new drug design, is teaming up with Chiesi Group. Under the agreement, Iktos’s de novo generative design software Makya will be used…
…bring complementary capabilities and expertise into the institute. GSK has leading capabilities in human genetics and functional genomics, and an in-house artificial intelligence and machine learning function, including its AI…
Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company, has announced that the first healthy volunteer has been dosed in a first-in-human microdose trial of ISM001-055. What is ISM001-055? ISM001-055…
Quris, an artificial intelligence (AI) company in the pharmaceutical industry, has launched a clinical prediction AI platform to predict which drug candidates will safely work in humans. This will improve…
…discovery: synthetic libraries, which is the specialty of Twist; in vivo discovery through animal models; and artificial intelligence models. With the anticipated acquisition of Abveris, Twist will have expertise in…
…since 2020.” According to GlobalData’s Pharma Intelligence Center, Hansoh Pharma’s co-development partnership with Silence Therapeutics is the third biggest siRNA-based strategic alliance globally in terms of the deal’s overall value…
…the innovation occurring at the health-data interface, we can reinforce the UK’s position as a major force in artificial intelligence, health and life sciences, and encourage crucial investment in companies…
…paid to two novel compounds being used to treat tuberculosis6. How artificial intelligence can predict drug resistance from signatures in the DNA sequence7 How these data8contributed to the first list…
…candidate from billions of potential antibody sequences is laborious and expensive and, in many cases, fails to identify functional antibodies. Recent advances in protein structure prediction, artificial intelligence (AI) algorithms,…
…website, which is enabling customers to mine its biospecimen repository and related clinical database using artificial intelligence (AI) and machine learning (ML) applications to advance scientific knowledge of different diseases….
BioIVT has added advanced tissue, biofluid and cell search and e-commerce capabilities to its website, which is enabling customers to mine its biospecimen repository and related clinical database using artificial…
…trends and analysis; and articles and intelligence from the DDW quarterly publication including archived issues. To download the DDW app for Apple devices click here. To download the DDW app…
Artificial Intelligence (AI) is the simulation of human intelligence processes by machines, particularly computer systems, and finds itself at a climactic moment for its use within the drug discovery industry,…
…Premium app-only content; the latest industry news brought to you as it happens; interviews; market reports; updates on the latest technology; trends and analysis; and articles and intelligence from the…
…Exscientia has announced a Phase I clinical study of DSP-0038 in the US for the treatment of Alzheimer’s disease psychosis. DSP-0038 is the third molecule created using Exscientia’s Artificial Intelligence…
…will focus on the application of new technologies for analysing the gut microbiome and the application of artificial intelligence techniques to big datasets to uncover new opportunities across a broad…
